Tag: Belluscura
Belluscura looks to wound care market
December 4, 2024HME News Staff
LONDON - Belluscura has entered into a joint venture with Separation Design Group and an undisclosed major medical device company to develop oxygen-based wound care solutions. The collaboration aims to address the growing wound care market through innovative treatments, including continuously diffused oxygen (CDO) therapy, which has shown potential in healing chronic wounds such as diabetic foot ulcers. The joint venture, in which Belluscura will act as the original equipment manufacturer (OEM),...
In brief: Rotech agreement, Merits USA president, Belluscura financing
November 27, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea.
The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health.
“Partnering...
Belluscura secures $4M
November 25, 2024HME News Staff
LONDON and PLANO, Texas – Belluscura has entered into a credit facility of up to $4 million with Houston-based Sallyport Commercial Finance to build out its manufacturing, distribution and sales. The funding, as well as Medicare clearance on Oct. 28, means the company can now formally launch its DISCOV-R portable oxygen concentrator. "Since releasing the DISCOV-R earlier this year in a limited direct-to-consumer launch, we have seen increasing month-on-month demand for the product,”...
In brief: CMS to end CHOPD, Lincare CEO to lead CQRC
June 19, 2024HME News Staff
WASHINGTON – CMS has announced that payments under the Accelerated and Advance Payment (AAP) Program for the Change Healthcare/Optum Payment Disruption (CHOPD) will conclude on July 12, 2024.
Launched in early March, the CHOPD payments were designed to ease cash flow disruptions experienced by some Medicare providers and suppliers, such as hospitals, physicians and pharmacists, due to the unprecedented cyberattack that took health care electronic data interchange Change Healthcare...
Belluscura shares performance update
June 17, 2024HME News Staff
LONDON and PLANO, Texas – Belluscura says sales of the X-PLOR portable oxygen concentrator in the United States were $820,000 in the three months to May 2024. The company says it recorded sales of $450,000 in May alone, its highest recorded monthly sales figure, across both direct-to-consumer and business-to-business channels. Belluscura says testing and validation of its DISCOV-R POC remains on schedule to ship in June. The company plans to initially sell the device through its DTC channel,...
In brief: Rehab Medical hits milestone, JANZ supports medics, Belluscura partners with Sunset
February 14, 2024HME News Staff
INDIANAPOLIS – Rehab Medical now has 100 assistive technology professionals (ATPs), a milestone it recently celebrated at a two-day annual conference in downtown Indianapolis.
“This milestone is a great achievement for us, and we are very proud to celebrate it,” said President Kevin Gearheart. “It is also the first of many milestones we expect to cross. We have an outstanding team, and this is just the beginning.”
Reaching the milestone is instrumental...
Belluscura, Sunset Healthcare partner
February 13, 2024HME News Staff
LONDON and PLANO, Texas – Belluscura's X-PLOR portable oxygen concentrator will be offered to more than 1,600 customers of Chicago-based Sunset Healthcare Solutions under a new distribution partnership. The partnership will also include Belluscura’s DISCOV-R POC in the second quarter, when it becomes available to DME providers. "We welcome the new partnership with Sunset Healthcare Solutions, which will provide over 1,600 health care businesses with access to our innovative products...
Belluscura announces increased offer
January 22, 2024HME News Staff
LONDON and PLANO, Texas – The boards of Belluscura and TMT Acquisition have announced the terms of a recommended share offer to be made by Belluscura for the whole of the issued and to be issued share capital of TMT Acquisition. Having regard to the Belluscura share price in recent weeks, the companies have agreed on an increase in the number of new Belluscura shares to be offered in exchange for TMT acquisition shares. The value of a TMT acquisition share under the offer, based on the closing...
In brief: Senators’ demands, F&P’s new execs, Belluscura’s green light
December 21, 2023HME News Staff
WASHINGTON – A group of senators has asked CMS to collect and publish more Medicare Advantage data to help lawmakers and regulators better understand the impact of these plans.
AAHomecare provided the following analysis of the group's new letter to CMS Administrator Chiquita Brooks-Lasure:
The senators cite “concerning trends” in Medicare Advantage and point to a 2019 HHS OIG study that “found that among requests MA plans denied, 13% of prior...
Belluscura gets green light in China
December 20, 2023HME News Staff
LONDON and PLANO, Texas – Belluscura has received approval from the National Medical Products Administration to distribute the X-PLOR portable oxygen concentrator in China. China is part of the licensed territory covered by the exclusive license agreement with InnoMax Medical Device Technologies announced in August 2023. "We are delighted to have received approval in China which has taken over approximately 10 months,” said Bob Rauker, CEO. “This enables us to launch sales...